| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |